These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 15366740)
1. Retrospective study of women presenting with axillary metastases from occult breast carcinoma. Blanchard DK; Farley DR World J Surg; 2004 Jun; 28(6):535-9. PubMed ID: 15366740 [TBL] [Abstract][Full Text] [Related]
2. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases. Wang X; Zhao Y; Cao X Breast J; 2010; 16(1):32-7. PubMed ID: 20465598 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of occult breast cancer in 44 cases]. Lu S; Liu H Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):550-2. PubMed ID: 22093638 [TBL] [Abstract][Full Text] [Related]
4. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362 [TBL] [Abstract][Full Text] [Related]
5. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678 [TBL] [Abstract][Full Text] [Related]
7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180 [TBL] [Abstract][Full Text] [Related]
8. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Rosen PP; Kimmel M Hum Pathol; 1990 May; 21(5):518-23. PubMed ID: 2338331 [TBL] [Abstract][Full Text] [Related]
9. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer. Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099 [TBL] [Abstract][Full Text] [Related]
10. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712 [TBL] [Abstract][Full Text] [Related]
11. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma. Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B Tumori; 2014; 100(6):600-4. PubMed ID: 25688492 [TBL] [Abstract][Full Text] [Related]
12. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Kuerer HM; Newman LA; Buzdar AU; Hunt KK; Dhingra K; Buchholz TA; Binkley SM; Ames FC; Feig BW; Ross MI; Hortobagyi GN; Singletary SE Am J Surg; 1998 Dec; 176(6):502-9. PubMed ID: 9926779 [TBL] [Abstract][Full Text] [Related]
13. Occult breast carcinoma presenting with axillary lymph node metastases. Medina-Franco H; Urist MM Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889 [TBL] [Abstract][Full Text] [Related]
14. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173 [TBL] [Abstract][Full Text] [Related]
15. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Vlastos G; Jean ME; Mirza AN; Mirza NQ; Kuerer HM; Ames FC; Hunt KK; Ross MI; Buchholz TA; Buzdar AU; Singletary SE Ann Surg Oncol; 2001 Jun; 8(5):425-31. PubMed ID: 11407517 [TBL] [Abstract][Full Text] [Related]
17. Axillary node interventions in breast cancer: a systematic review. Rao R; Euhus D; Mayo HG; Balch C JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924 [TBL] [Abstract][Full Text] [Related]
18. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Yegiyants S; Romero LM; Haigh PI; DiFronzo LA Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977 [TBL] [Abstract][Full Text] [Related]
19. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Oruwari JU; Chung MA; Koelliker S; Steinhoff MM; Cady B Am J Surg; 2002 Oct; 184(4):307-9. PubMed ID: 12383889 [TBL] [Abstract][Full Text] [Related]
20. Contralateral axillary lymph node metastasis as the first evidence of locally recurrent breast carcinoma. Jaffer S; Goldfarb AB; Gold JE; Szporn A; Bleiweiss IJ Cancer; 1995 Jun; 75(12):2875-8. PubMed ID: 7773936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]